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]\Iuch commercial literature for corticosteroid
ointments and creams carries the warning that
the use of the product is contraindicated in the
presence of fungal infection. This interdiction
likely arose from experimental and clinical
observations in which certain fungal infections
were initiated more easily or made clinically
worse by parenteral administration of the glu-
coeorticoid hormones (1, 2). However, such
work does not warrant the generalization that
any fungal infection contraindieates all use of
steroid. More specifically, there is no evidence
that steroids applied topically to the skin in
their customary strengths and vehicles will
aggravate a cutaneous infection that is due to
dermatophyte fungal species.
To the contrary, our clinical experience has
shown that such products often relieve the dis-
tressing inflammation and itching caused by
such infections. Zimmer and Schönborn (3)
recently reported a lack of effect of a corticos-
teroid, prednisolone, on the growth of seven
fungal species. They further tested an antifungal
agent, dibenzythiotetrahydrothiadiazine, which
totally inhibited Trichophyton rubrum. They
then used an ointment containing the two agents
and cured 35 of 48 patients with mycoses.
Lipets (4) reported good immediate results
from the local application of prednisolone oint-
ment to acutely inflamed foci of childhood
dermatophytosis. Such results are analogous to
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the findings of Fritsch and Fritsch (5) and
Davis, et al. (6) who found topical steroid
creams highly beneficial in the healing of bac-
terially-infected dermatitis.
Preliminary studies, involving important
dermatophyte and contaminant species grown
in the presence of varying concentrations of
common corticosteroids, suggested that the
steroids did not affect their growth, in vitro. A
more precise technique was developed to meas-
ure growth. This report concerns an investiga-
tion of the growth, in vitro, of two common
pathogenic dermatophytes when exposed to
various concentrations of four topically em-
ployed corticosteroids. Further, the growth
studies combined the steroids with either tol-
naftate or griseofulvin to test whether the pres-
ence of a steroid would alter the effect of these
anti-dermatophyte drugs.
MATERIALs AND METHOD5
Fresh cultures of Trichophyton rubruns and
Trichophylon men.tagrophytes were obtained from
the feet of patients who had received no oral or
topical auti-fungal treatment. The two derma-
tophytes were isolated on a modified Sabouraud's
agar containing chloramphenicol and cyclohcxam-
ide (Mycosel®), and subcultured twice before
being planted on the special madia detailed in
Table I.
The steroids employed were triamcinolone ace-
tonide, flurandrenolone, fluocinolone acetonide,
and betamethasone. Each was incorporated into
the agar at concentrations of 0.1%, 0.01%, and
0.001%. They are extremely insoluble in water,
but soluble in dimethylformamide (DMF). Pre-
liminary studies showed that 125% DMF in the
final agar was a satisfactory concentration; con-
trol plates assessed the effect of the solvent alone.
Tolnaftate is likewise insoluble in water. Poly-
ethylene glycol-400 (PEG), 13.75% of the final
agar, was found satisfactory to maintaia solubility
of the tolnaftate in concentrations ranging from
0.03125 xg/ml to 0.2500 ig/ml. Control plates
again assessed the effect of the solvent alone.
Preliminary studies had shown this range of con-
centrations served best to identify the minimum
inhibitory concentration (MIC) of tolnaftate, a
concentration which prevented growth of our par-
ticular organisms. The MIC proved to be differ-
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TABLE I
Types and numbers of media inoculated
Control plates Number of plates Contents of plates
Agar Control
Control for PEG (Tolnaf-
tate Solvent)
Control for DMF (Steroid
Solvent)
Control for PEG & DMF
(Combination)
MIC-G Control
MIC-T Control
Steroid (Tr) Control
Steroid (Fr) Control
Steroid (Fo) Control
Steroid (B) Control
10
10
10
10
4 each
4 each
2 each
2 each
2 each
2 each
Agar
Agar, PEG
Agar, DMF
Agar, DMF, PEG
Agar, DMF, PEG
0.75, 1.5, and 3.0 sg. G/ml of agar
Agar, DMF, PEG
0.03125, 0.0625, 0.125, and 0.250 sg. T/ml of
agar
Agar, DMF, PEG
0.001%, 0.01%, and 0.1% TrIm! of agar
Agar, DMF, PEG
0.001%, 0.01%, and 0.1% Fr/mI of agar
Agar, DMF, PEG
0.001%, 0.01%, and 0.1% Fo/mI of agar
Agar, DMF, PEG
0.001%, 0.01%, and 0.1% B/ml of agar
Experimental plates
T-Tr
T-Fr
T-Fo
T-B
G-Tr
G-Fr
G-Fo
2 each X 9 combinations
2 each X 9 combinations
2 each X 9 combinations
2 each X 9 combinations
2 each X 9 combinations
2 each X 9 combinations
2 each X 9 combinations
Agar, DMF, PEG
0.03125, 0.0625, and 0.125 sg T/ml of agar*
each with
0.001%, 0.01%, and 0.1% Tr/ml of agar
Agar, DMF, PEG
0.03125, 0.0625, and 0.125 g T/m! of agar*
each with
0.001%, 0.01%, and 0.1% Fr/mI of agar
Agar, DMF, PEG
0.03125, 0.0625, and 0.125 .sg T/ml of agar*
each with
0.001%, 0.01%, and 0.1% Fo/mi of agar
Agar, DMF, PEG
0.03125, 0.0625, and 0.125 g T/ml of agar*
each with
0.001%, 0.01%, and 0.1% B/ml of agar
Agar, DMF, PEG
0.75, 1.5, and 3.0 g G/ml of agar
each with
0.001%, 0.01%, and 0.1% Tr/ml of agar
Agar, DMF, PEG
0.75, 1.5, and 3.0 g G/ml of agar
each with
0.001%, 0.01%, and 0.1% Fr/mI of agar
Agar, DMF, PEG
0.75, 1.5 and 3.0 g G/ml of agar
each with
0.001%, 0.01%, and 0.1% Fo/ml of agar
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TABLE I (continued)
Control plates Number of plates Contents of plates
G-B 2 each X 9 combinations Agar, DMF, PEG
0.75, 1.5 and 3.0 pg G/ml of agar
each with
0.001%, 0.01%, and 0.1% B/mI of agar
* These values are for T. rubrum. The corresponding values for T. mentagrophytes are 0.0625, 0.125,
and 0.250 pg T/ml of agar.
Key:
Agar = Mycosel agar prepared with sterile water
MIC = Minimum inhibitory concentration
DMF = Dimethylformamide, always held constant at 1.25%
PEG = Polyethylene Glycol-400, always held constant at 13.75%
C = Griseofulvin
T = Tolnaftate
Tr = Triamcinolone acetonide
Fr = Flurandrenolone
Fo = Fluocinolone acetonide
B = Betamethasone.
ent for the two species and different from values
published by the manufacturer, which suggests
that investigators must always establish an MIC
appropriate to their organism.
Griseofulvin is sufficiently soluble in water to
permit concentrations in the test plates of 0.75,
1.50 and 3.00 pg/ml. These concentrations were
selected because they permitted us to identify
a measurable inhibiting effect on growth during
preliminary experiments.
Sterile technique was employed in preparing
and inoculating the agar. Eight-cm. plastic Petri
dishes were inoculated on the day of their prepa-
ration. Twenty agar plugs were cut from cultures
20 days old, using a 4 mm. cutaneous biopsy
punch. These plugs were dispersed by shaking
with 10 cc. of sterile physiologic saline solution
until the suspension appeared uniform. One drop
of the prepared inoculum was placed in the center
of each plate, using a sterile syringe and 18 gauge
needle. A sterile steel rod, specially prepared to
be exactly 2 cm. in length, was then set on the
surface of the agar. The plates were incubated at
room temperature (20°.-22° C.) at relative hu-
midity of approximately 40% during the months
of June nnd July. Table I shows the number,
types and exact composition of control and ex-
perimental media inoculated in this study. The
entire set of plates was inoculated with T. rubrum,
and duplicated with T. men.tegrophytes. It should
be noted that constant amounts of chlorampheni-
col and cyclohexamide were used of necessity in
all control and experimental plates to avoid con-
tamination; therefore, alterations of growth in ex-
perimental plates could be attributed to the other
drugs added. Likewise, the concentration of sol-
vents for the steroids and antifungal agents were
kept constant with varying concentrations of
solute, since the solvents themselves were shown to
affect fungal growth.
Measurements of growth were made on days
12, 27, and 47 for T. rubrum, and on days 7, 15, 23,
and 48 for T. mentagrophyles. We photographed
the colony from the back side of the Petri dish,
reducing contamination by not opening the dish.
Kodachrome® color film was used in a 35 mm.
camera at a standard distance of 24 inches. Any
type of camera or film could be used to obtain a
transparency for projection upon a flat surface
(wall). Since the colonies only approximated per-
fect circles, four diameters of the projected image
were measured with a meter-stick: vertical, hori-
zontal, and the two 45° obliques. These lengths and
the size of the projection of the steel rod permitted
computation of the average "width" (a numerical
expression reflecting the size) of the colony itself,
according to the formula:
Where
=
D1 + D2 D3 + D4
><
W = "the width" of the actual colony in cm.,
Dn = diameter of projected colony in cm.,ft = actual length of steel rod in cm., and
= length of projected image of the steel rod
in cm.
This technique permits a precision of measure-
ment that proved to exceed the needs of this
study, since variations of a few mm. in colony
width could not reasonably be considered signifi-
cant in a biological system of this type. The more
certain end-point, growth vs. no-growth, is clearly
more satisfactory and was ultimately used in the
interpretations.
If colonial growth occurred in an experimental
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WEEKS
plate, it was remarkably similar to its duplicate
and to the growth in the corresponding control
plate, making possible an identification of drug
effect on the criterion of growth vs. nc-growth. A
chi-square test of the type described by Lewis (7)
serves to test the hypothesis that the "dose-re-
sponse curves" (experimental vs. control) are
identical. A statistically significant result at the
.05 level (P < .05) means that the probability of
observing such discrepant values by chance alone
6 4 isless than 1/20.
Average diameter of colonies of T. mentagrophytes, in cm, when grown in the presence of tolnaftate
Type of agar Tiia0t* Day 7 Day 15 Day 23 Day 48
DMF-PEG Control 0 1.1 (1O/1O)t 2.0 (10/10) 2.3 (10/10) 2.2 (10/10)
Steroid Control
Tr
Fr
Fo
B
0
0
0
0
1.3 (6/6)
1.2 (6/6)
1.2 (6/6)
1.2 (6/6)
2.1 (6/6)
2.2 (6/6)
2.0 (6/6)
2.0 (6/6)
2.3 (6/6)
2.5 (6/6)
2.2 (6/6)
2.1 (6/6)
2.3 (6/6)
2.4 (6/6)
2.3 (6/6)
2.1 (6/6)
Toloaftate Controls for MIC .0625
.125
.25
1.2 (4/4)
1.0 (4/4)
0 (0/4)
1.5 (4/4)
1.5 (4/4)
0 (0/4)
1.7 (4/4)
1.5 (4/4)
0 (0/4)
t
1.5 (4/4)
0 (0/4)
Tr (all concentrations) .0625
.125
.25
1.1 (6/6)
0 (0/6)
0 (0/6)
1.5 (6/6)
0 (0/6)
0 (0/6)
1.7 (6/6)
1.4 (6/6)
0 (0/6)
1.7 (6/6)
1.4 (6/6)
0 (0/6)
Fr (all concentrations) .0625
.125
.25
.5 (3/6)
0 (0/6)
0 (0/6)
1.5 (6/6)
1.2 (6/6)
0 (0/6)
1.6 (6/6)
1.3 (6/6)
0 (0/6)
1.6 (6/6)
1.3 (6/6)
0 (0/6)
Fo (all concentrations) .0625
.125
.25
1.3 (6/6)
1.2 (6/6)
0 (0/6)
1.6 (6/6)
1.5 (6/6)
1.2 (6/6)
1.7 (6/6)
1.5 (6/6)
1.3 (6/6)
1.8 (6/6)
t
t
B (all concentrations) .0625
.125
.25
1.3 (6/6)
1.0 (5/6)
0 (0/6)
1.7 (6/6)
1.5 (6/6)
0 (0/6)
1.8 (6/6)
1.5 (6/6)
1.3 (6/6)
1.8 (6/6)
1.5 (6/6)
1.2 (6/6)
'K jag, of Tolnaftate/ml of agar.
t The fractions in parentheses indicate the number of colonies in which growth occurred, compared
to the number inoculated.
tMeasurement not obtained for technical reasons. Abbreviations are identified in the Key f or
Table I.
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Fcc. 1. Graph illustrating the inhibitory effect
of PEG, DMF, and the combination of PEG and
DMF on the growth of T. mcntagrophytes. Each
point plotted represents the average diameter of
ten colonies. (PEG = Mycosel agar containing
13.75% polyethylene glycol-400; DMF = Mycosel
agar containing 125% dimethylformamide.)
TABLE II
RESULTS
We found remarkably good agreement in
duplicate plates regarding the presence or de-
gree of growth. Also gratifying was tbe almost
complete absence of fungal or bacterial con-
tamination of the plates.
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TABLE III
Average diameter of colonies of T. Mentagrophytes, 'in cm, when grown in the presence of griseofulvim
Type of Agar Griseofulvin* Day 7
1.1 (10/10)t
Day 15
2.0 (10/10)
Day 23
2.3 (10/10)
Day 48
2.2 (10/10)DMF-PEG Control 0
Steroid Control
Tr
Fr
Fo
B
0
0
0
0
1.3 (6/6)
1.2 (6/6)
1.2 (6/6)
1.2 (6/6)
2.0 (6/6)
2.3 (6/6)
2.0 (6/6)
2.0 (6/6)
2.3 (6/6)
2.5 (6/6)
2.4 (6/6)
2.1 (6/6)
2.3 (6/6)
2.4 (6/6)
2.3 (6/6)
2.1 (6/6)
Griseofulvin Controls for MIC .75
1.5
3.0
1.2 (4/4)
1.3 (4/4)
1.2 (4/4)
1.9 (4/4)
1.7 (4/4)
1.4 (4/4)
2.2 (4/4)
2.1 (4/4)
1.8 (4/4)
2.3 (4/4)
2.1 (4/4)
1.8 (4/4)
Tr (all concentrations) .75
1.5
3,0
1.3 (6/6)
1.3 (6/6)
1.2 (6/6)
2.1 (6/6)
1.8 (6/6)
1.4 (6/6)
2.5 (6/6)
2.2 (6/6)
1.7 (6/6)
2.6 (6/6)
2.3 (6/6)
1.7 (6/6)
Fr (all concentrations) .75
1.5
3.0
1.4 (6/6)
1.2 (6/6)
1.4 (6/6)
2.1 (6/6)
1.8 (6/6)
1.5 (6/6)
2.6 (6/6)
2.2 (6/6)
1.8 (6/6)
2.8 (6/6)
2.3 (6/6)
1.9 (6/6)
Fo (all concentrations) .75
1.5
3.0
1.3 (6/6)
1.2 (6/6)
1.2 (6/6)
2.0 (6/6)
1.5 (6/6)
1.5 (6/6)
2.4 (6/6)
2.0 (6/6)
1.6 (6/6)
2.4 (6/6)
2.1 (6/6)
1.7 (6/6)
B (all concentrations) .75
1.5
3.0
1.2 (6/6)
1.2 (6/6)
1.2 (6/6)
2,0 (6/6)
1.7 (6/6)
1.4 (6/6)
2.4 (6/6)
2.1 (6/6)
1.5 (6/6)
2.4 (6/6)
2.1 (6/6)
1.7 (6/6)
* g. of Griseofulvin/ml of agar.
t The fractions in parentheses indicate the number of colonies in which growth occurred, compared
to the number inoculated.
Abbreviations are identified in the Key for Table I.
The agents used to dissolve the experi-
mental drugs in the agar were themselves re-
sponsible for an inhibition of fungal growth.
Fig. 1 illustrates the inhibitory effect of PEG
and DMF and the additive inhibitory effect of
their combination on the growth of T. mentag-
rophytes. A similar result occurred with T.
rub rum.
For none of the 3 concentrations of the 4
steroids tested was there any evidence of effect.
That is, these concentrations of the particular
drugs appeared neither to encourage nor in-
hibit the growth, in vitro, of these two patho-
genic dcrmatophytes. The data regarding T.
mentagrophytes are given in Tables II and
III, and the data for T. rubrum in Tables IV
and V.
The three concentrations of each steroid
gave essentially identical results. Therefore,
the data summarized in Tables II through V
are listed as total colonies tested with that
steroid, irrespective of concentration. The dose-
response patterns of the number of plates that
showed or failed to show growth were com-
pared in a chi-square format as shown in Table
VI. In the following instances the presence of
steroid appeared to produce a statistically sig-
nificant shift in the MIC of either tolnaftate or
griseofulvin:
1. Triamcinolone acetonide increased the anti-
fungal effect (P < .05) of tolnaftate against
T. mentagrophytes as measured on days 7 and
15, but the statistical significance of the effect
was lost by day 23. In contrast, fluocinolone
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TABLE IV
Average diameter of colonies of T. rubrum, in cm, when grown in the presence of tolnaftate
Type of Agar To1naftate Day 12 Day 27 Day 47
DMF-PEG Control 0 1.3 (10/10)1 1.4 (10/10) 1.5 (10/10)
Steroid Control
Tr
Fr
Fo
B
0
0
0
0
1.2 (6/6)
1.2 (6/6)
1.3 (6/6)
1.6 (6/6)
1.4 (6/6)
1.5 (6/6)
1.4 (6/6)
1.5 (6/6)
1.5 (6/6)
1.5 (6/6)
1.6 (6/6)
1.4 (6/6)
Tolnaftate Controls for MIC .03125
.0625
.125
0 (0/4)
0 (0/4)
0 (0/4)
1.5 (4/4)
1.3 (4/4)
0 (0/4)
1.5 (4/4)
1.2 (4/4)
0 (0/4)
Tr (all concentrations) .03125
.0625
.125
1.3 (5/6)
0 (0/6)
0 (0/6)
1.4 (6/6)
.6 (3/6)
0 (0/6)
1.5 (6/6)
.6 (3/6)
0 (0/6)
Fr (all concentrations) .03125
.0625
.125
1.3 (6/6)
0 (0/6)
0 (0/6)
1.3 (6/6)
.4 (4/6)
0 (0/6)
1.5 (6/6)
.3 (4/6)
0 (0/6)
Fo (all concentrations) .03125
.0625
.125
1.1 (6/6)
.6 (3/6)
0 (0/6)
1.3 (6/6)
1.2 (6/6)
0 (0/6)
B (all concentrations) .03125 1.2 (6/6)
.0625 1.1 (6/6)
.125 0 (0/6)
1.3 (6/6)
1.2 (6/6)
0 (0/6)
1.4 (6/6)
1.3 (6/6)
*g. of Tolnaftate/ml of agar.
t The fractions in parentheses indicate the number of colonies in which growth occurred, compared
to the number inoculated.
Measurement not obtained for technical reasons.
Abbreviations are identified in the Key for Table I.
acetonide decreased the antifungal effect of
tolnaftate on T. mentagrophytes (P < .05) at
day 23, although it did not do so earlier.
2. When tolnaftate was tested against T.
rubrum, its antifungal effect was decreased by
flurandrenolone (P < .05), fluocinolone ace-
tonide (P < .05), and betamethasone (P <
.01) as measured at day 12. By day 27 the dif-
ferences were rio longer statistically significant.
3. The action of griseofulvin against T.
mentagrophytes appeared not to be influenced
by the presence of steroid. However, the con-
centrations of griseofulvin proved not to be at
the MIC for this organism in the formal ex-
periment, and therefore we cannot draw a con-
clusion about a shift in the MIC.
4. The action of griseofulvin against T. rub-
rum was increased by all four steroids (P <
.05) measured at day 27. Griseofulvin concen-
trations of 3.0 pg/ml. prevented growth when
the steroids were present, whereas the organisms
grew in control plates of either griseofulvin or
steroid.
COMMENT
The data show that our strain of T. mentag-
rophytes was less sensitive than T. rubrum
to either tolnaftate or griseofulvin. Further-
more, the differences in amount and timing of
growth of the two test species means that con-
clusions based upon observations of one orga-
nism (or perhaps even one strain of an orga-
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TABLE V
Average diameter of colonies of T. rubrum, in cm, when grown in the presence of griseofulvin
Type of Agar Griseofulvin* Day 12 Day 27 Day 47
DMF-PEG Control 0 1.3 (10/10)t 1.4 (10/10) 1.5 (10/10)
1.5 (6/6)
1.5 (6/6)
1.6 (6/6)
1.4 (6/6)
Steroid Control
Tr
Fr
Fo
B
0
0
0
0
1.2 (6/6)
1.2 (6/6)
1.3 (6/6)
1.6 (6/6)
1.4 (6/6)
1.5 (6/6)
1.4 (6/6)
1.5 (6/6)
Griseolfulvin Controls for MIC .75
1.5
3.0
0 (0/4)
0 (0/4)
0 (0/4)
1.4 (4/4)
1.4 (4/4)
1.4 (4/4)
1.5 (4/4)
1.4 (4/4)
Tr (all concentrations) .75
1.5
3.0
.9 (4/6)
0 (0/6)
0 (0/6)
1.5 (6/6)
1.3 (6/6)
0 (0/6)
1.5 (6/6)
1.4 (6/6)
0 (0/6)
Fr (all concentrations) .75
1.5
3.0
.8 (4/6)
0 (0/6)
0 (0/6)
1.3 (6/6)
1.2 (6/6)
0 (0/6)
1.3 (6/6)
1.2 (6/6)
0 (0/6)
Fo (all concentrations) .75
1.5
3.0
.6 (3/6)
0 (0/6)
0 (0/6)
1.4 (6/6)
1.3 (6/6)
0 (0/6)
1.5 (6/6)
1.4 (6/6)
0 (0/6)
B (all concentrations) .75
1.5
3.0
1.0 (5/6)
0 (0/6)
0 (0/6)
1.4 (6/6)
1.3 (6/6)
0 (0/6)
1
1.4 (6/6)
0 (0/6)
* ig of Griseofulvin/mi of agar.
The fractions in parentheses indicate the number of colonies in which growth occurred, compared
to the number inoculated.
Measurement not obtained for technical reasons.
Abbreviations are identified in the Key for Table I.
nism) should be generalized only with great
caution.
This formal study confirmed the results of
the preliminary studies in showing no influence
of these particular steroid hormones on the
in vitro growth of the test organisms. However,
under some experimental circumstances the
steroids surprisingly fostered or impaired the
antifungal properties of the tolnaftate and
griseofulvin. The reason for these effects is un-
certain. However, many microorganisms have
the ability to utilize or transform steroid hor-
mones in highly selective ways (8). Such trans-
formations may have occurred with the two
organisms used here; producing no discernible
alteration in growth by themselves, such
(theoretical) transformations may have altered
the organism's susceptibility to a toxic agent.
The observed effects on in vitro growth sug-
gest that studying the combined action of
steroids and antifungal agents upon experimental
infection might be instructive.
SUMMARY
In vitro growth of two dermatophytes (T.
mentagrophytes and T. rubr'um) was measured
in the presence of varying concentrations of
four glucocorticosteroid hormones (triamcino-
lone acetonide, flurandrenolone, fluocinolone
acetonide, and betamethasone), two antifungal
agents (tolnaftate and griseofulvin), and com-
binations of the two classes of agents.
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TABLE VI
Example of data for chi-square computation, in-
volving T. mentagrophytes, lolnaftate, and in-
amcinolone acetonide, comparing frequency of
instances of growth in MIC plates compared to
steroid-tolnaftate plates
[TI 2 .125 .25
MIC inocula that grew
MIC inocula that did not grow
4
0
4
4
0
4
0
4
4
8
4
12
Tr inocula that grew
Tr inocula that did not grow
6 0
0 66 6
0
6
6
6
12
18
Chi-square = 10, therefore P < .05.
T} = Concentration of tolnaftate in g/ml of
a gar.
MIC = minimum inhibitory concentration.
Tr = triameinolone acetonide (total of all con-
centrations).
The agents used to dissolve the test drugs
in the agar were polyethylene glycol-400, and
dimethylformamide. Each had an inhibitory ef-
fect on fungal growth, and the combination had
an additive effect.
The steroids alone did not influence the
growth of the fungi under the experimental
conditions.
Although the steroid concentrations did not
seem to play a role, some of the agents used
showed a statistically significant effect in either
increasing or decreasing the antifungal effect
of tolnaftate and griseofulvin.
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